What is the definition of a clinically relevant donor HLA-specific antibody (DSA)?

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 299-300

  Hachem, R R ^a   Reinsmoen, N L ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; DITHIOTHREITOL; DONOR HLA SPECIFIC ANTIBODY; HLA ANTIBODY; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN BINDING; B LYMPHOCYTE; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT FIXATION; DESENSITIZATION; EDITORIAL; FLOW CYTOMETRY; GRAFT FAILURE; HLA SYSTEM; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; ADULT; HUMAN TISSUE; OUTCOME ASSESSMENT; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; LUNG; MALE; MORTALITY; PERIOPERATIVE PERIOD; PHYSIOLOGY; PROCEDURES;

DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT SURVIVAL; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; PERIOPERATIVE CARE; TRANSPLANT RECIPIENTS;

EID: 84921528019     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13079     Document Type: Editorial

References (6)

1. Zachary AA, Sholander JT, Houp JA, et al. Using real data for a virtual crossmatch. Hum Immunol 2009; 70: 574-579.
2. Appel JZ III, Hartwig MG, Cantu E III, et al. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. Transplantation 2006; 81: 1049-1057.
3. Tinckam KJ, Keshavjee S, Chaparro C, et al. Survival in sensitized lung transplant recipients with perioperative desensitization. Am J Transplant 2015; 15: 417-426.
4. Safavi S, Robinson DR, Soresi S, Carby M, Smith JD., De novo HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2014; 33: 1273-1281.
5. Smith JD, Ibrahim MW, Newel H, et al. Pre-transplant donor HLA-specific antibodies: Characteristics causing detrimental effects on survival after lung transplantation. J Heart Lung Transplant 2014; 33: 1074-1082.
6. Chen G, Sequeira F, Tyan DB., Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Human Immunol 2011; 72: 849-858.